지속적 신대체요법(CRRT) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 모달리티별, 최종사용자 지역별, 경쟁별(2020-2030년)

The Global Continuous Renal Replacement Therapy Market, valued at USD 1.32 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 2.20 Billion by 2030. Continuous Renal Replacement Therapy (CRRT) represents a continuous extracorporeal blood purification technique employed for critically ill patients experiencing acute kidney injury or severe fluid overload, primarily within intensive care settings. The market's expansion is fundamentally driven by the escalating global incidence of acute kidney injury, the increasing geriatric population which inherently presents a higher predisposition to renal complications, and ongoing technological advancements in CRRT systems.

Key Market Drivers

The Global Continuous Renal Replacement Therapy market is significantly influenced by the increasing incidence of acute kidney injury and chronic kidney disease. These conditions frequently necessitate advanced renal support, directly expanding the patient pool eligible for CRRT. The widespread nature of renal ailments is underscored by recent findings, where according to EurekAlert! , in October 2025, reporting on the Global Burden of Disease Study 2023, kidney dysfunction was identified among the top ten risk factors for global health loss in 2023. This pervasive health challenge creates a continuous and growing demand for effective therapeutic interventions like CRRT.

Key Market Challenges

The substantial cost associated with Continuous Renal Replacement Therapy equipment and disposable sets represents a significant impediment to market expansion. This financial burden directly affects healthcare systems globally, particularly those operating under budget constraints, by limiting their capacity for equipment acquisition and sustained operational expenses. According to a study published in *Critical Care Explorations* in June 2023, the daily cost of CRRT was estimated to be approximately $872 from a U. S. healthcare payer perspective, indicating a considerable financial commitment for healthcare facilities.

Key Market Trends

The integration of artificial intelligence (AI) is significantly enhancing the precision and operational efficiency of Continuous Renal Replacement Therapy. AI algorithms can analyze extensive patient data to predict responses, optimize fluid balance, and automate medication dosing, thereby minimizing human error and supporting more consistent, tailored treatments in critical care. Fresenius Medical Care, in October 2023, announced its strategic initiative to develop AI models utilizing anonymized data from over 540,000 dialysis patients. This endeavor is aimed at refining various aspects of dialysis therapies, including the optimization of erythropoietin stimulating agents and iron therapies. Such advancements are critical for transitioning from reactive interventions to proactive, data-driven patient management. While the practical application of AI in CRRT is still developing, research into its potential to enhance CRRT delivery has seen substantial growth in recent years, highlighting its recognized importance within the industry.

Key Market Players

• Baxter International, Inc
• Fresenius Ag & Co.
• Nikkiso Co., Ltd
• Braun Melsungen Ag
• Medtronic Plc
• Asahi Kasei Corporation
• Toray Medical Co., Ltd.
• Informed SA
• Nipro Corporation
• Medica SPA

Report Scope:

In this report, the Global Continuous Renal Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Renal Replacement Therapy Market, By Product:

• Dialysates and Replacement Fluids
• Disposables
• Hemofilters
• Bloodline Sets & Tubes
• Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality:

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous hemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

Continuous Renal Replacement Therapy Market, By End User:

• Hospital & Clinics
• Ambulatory Surgical care
• Others

Continuous Renal Replacement Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Continuous Renal Replacement Therapy Market.

Available Customizations:

Global Continuous Renal Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Renal Replacement Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, Other Disposables, CRRT Systems)
  • 5.2.2. By Modality (Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous hemodialysis (CVVHD), Slow continuous ultrafiltration (SCUF))
  • 5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Continuous Renal Replacement Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Modality
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Continuous Renal Replacement Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Modality
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Continuous Renal Replacement Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Modality
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Continuous Renal Replacement Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Modality
      • 6.3.3.2.3. By End User

7. Europe Continuous Renal Replacement Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Modality
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Continuous Renal Replacement Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Modality
      • 7.3.1.2.3. By End User
  • 7.3.2. France Continuous Renal Replacement Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Modality
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Continuous Renal Replacement Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Modality
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Continuous Renal Replacement Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Modality
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Continuous Renal Replacement Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Modality
      • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Renal Replacement Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Modality
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Continuous Renal Replacement Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Modality
      • 8.3.1.2.3. By End User
  • 8.3.2. India Continuous Renal Replacement Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Modality
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Continuous Renal Replacement Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Modality
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Continuous Renal Replacement Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Modality
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Continuous Renal Replacement Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Modality
      • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Renal Replacement Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Modality
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Continuous Renal Replacement Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Modality
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Continuous Renal Replacement Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Modality
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Continuous Renal Replacement Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Modality
      • 9.3.3.2.3. By End User

10. South America Continuous Renal Replacement Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Modality
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Continuous Renal Replacement Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Modality
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Continuous Renal Replacement Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Modality
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Continuous Renal Replacement Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Modality
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Continuous Renal Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Baxter International, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius Ag & Co.
• 15.3. Nikkiso Co., Ltd
• 15.4. Braun Melsungen Ag
• 15.5. Medtronic Plc
• 15.6. Asahi Kasei Corporation
• 15.7. Toray Medical Co., Ltd.
• 15.8. Informed SA
• 15.9. Nipro Corporation
• 15.10. Medica SPA

16. Strategic Recommendations

17. About Us & Disclaimer